Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury.
Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury.
复制标题
DOI:
10.1038/sc.2010.67
复制
发表时间:
2011-01
期刊:
影响因子:
2.2
通讯作者:
Kitzman, P. H.
中科院分区:
文献类型:
--
作者:
Rabchevsky, A. G.;Patel, S. P.;Duale, H.;Lyttle, T. S.;O'Dell, C. R.;Kitzman, P. H.
Utilizing a complete transection spinal cord injury (SCI) model at the fourth thoracic vertebral level in adult rats, we evaluated whether blocking noxious stimuli below the injury diminishes abnormal somatic and autonomic motor reflexes, manifested in muscular spasticity and hypertensive autonomic dysreflexia, respectively. Gabapentin (GBP) is well-tolerated and currently used to manage neuropathic pain in the SCI population; evidence suggests it acts to decrease presynaptic glutamate release. Since clinical evidence indicates that GBP may suppress muscular spasticity in the chronic SCI population, we hypothesized that preventing neurotransmission of noxious stimuli with GBP eliminates a critical physiological link to these distinct, debilitating SCI-induced secondary impairments. Behavioural assessments of tail muscle spasticity and mean arterial blood pressure responses to noxious somatic and/or visceral stimulation were used to test the effects of GBP on these abnormal reflexes. Lexington, Kentucky We employed femoral artery catheterization and radio-telemetric approaches to monitor blood pressure alterations in response to noxious colorectal distension (CRD) weeks after complete SCI. At 2-3 weeks post-SCI, acute GBP administration (50 mg/kg, i.p.) significantly attenuated both autonomic dysreflexia and tail spasticity induced by noxious stimuli compared to saline-treated cohorts. These results demonstrate, for the first time, that a single pharmacological intervention, GBP, can effectively attenuate the manifestation of both muscular spasticity and autonomic dysreflexia in response to noxious stimuli.
登录
查看更多内容
影响因子:
5.3
作者:
Cameron, AA;Smith, GM;Rabchevsky, AG
通讯作者:
Rabchevsky, AG
DOI:
10.1152/ajpheart.1995.268.5.h2077
发表时间:
1995-05-01
影响因子:
4.8
作者:
KRASSIOUKOV, AV;WEAVER, LC
通讯作者:
WEAVER, LC
DOI:
10.1152/ajpheart.1997.272.2.h625
发表时间:
1997-02-01
影响因子:
4.8
作者:
Maiorov, DN;Weaver, LC;Krassioukov, AV
通讯作者:
Krassioukov, AV
影响因子:
3.3
作者:
Kitzman, P. H.;Uhl, T. L.;Dwyer, M. K.
通讯作者:
Dwyer, M. K.
影响因子:
5.3
作者:
Kitzman, P
通讯作者:
Kitzman, P